Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • edgemaster72@lemmy.world
    link
    fedilink
    English
    arrow-up
    25
    arrow-down
    1
    ·
    1 year ago

    Weren’t they hacked recently? Are the drugmakers sure the data isn’t cheaper on the black market?

    • PeterPoopshit@lemmy.world
      link
      fedilink
      English
      arrow-up
      14
      ·
      edit-2
      1 year ago

      They’re why they’re only paying “millions”. To big pharma, $20m is just pocket change. Now no one will accuse them of downloading it off the dark net.